RELAY THERAPEUTICS INC (RLAY) Forecast, Price Target & Analyst Ratings

Q: What do analysts expect the price target to be for RELAY THERAPEUTICS INC (RLAY)?

18 analysts have analysed RLAY and the average price target is 17.43 USD. This implies a price increase of 40.02% is expected in the next year compared to the current price of 12.45.

Q: What is the next earnings date for RLAY stock?

RELAY THERAPEUTICS INC (RLAY) will report earnings on 2026-04-30.

NASDAQ:RLAY • US75943R1023

12.45 USD

-0.09 (-0.72%)

At close: Apr 6, 2026

12.45 USD

0 (0%)

After Hours: 4/6/2026, 4:30:01 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RELAY THERAPEUTICS INC (RLAY).

Consensus Price Target

Price Target

$17.43

+ 40.02% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Apr 30, 2026
Period: Q1 / 2026
EPS Estimate: -$0.39
Revenue Estimate: 524.576K

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

87.78%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$17.43

Upside

+ 40.02%

From current price of $12.45 to mean target of $17.43, Based on 18 analyst forecasts

Low

$13.13

Median

$17.34

High

$23.10

Price Target Revisions

1 Month

17.50%

3 Months

17.06%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for RLAY. The average price target is 17.43 USD. This implies a price increase of 40.02% is expected in the next year compared to the current price of 12.45.

The average price target has been revised upward by 17.06% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

87.78%

RLAY was analyzed by 18 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about RLAY.

In the previous month the buy percentage consensus was at a similar level.

RLAY was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2026-03-23	HC Wainwright & Co.	Maintains	Buy -> Buy
2026-03-17	Citizens	Maintains	Market Outperform -> Market Outperform
2026-03-17	Wells Fargo	Maintains	Overweight -> Overweight
2026-03-13	Guggenheim	Maintains	Buy -> Buy
2026-02-27	Wells Fargo	Maintains	Overweight -> Overweight
2026-01-26	Oppenheimer	Upgrade	Perform -> Outperform
2025-12-12	Wells Fargo	Upgrade	Equal-Weight -> Overweight
2025-11-07	Wells Fargo	Maintains	Equal-Weight -> Equal-Weight
2025-08-26	HC Wainwright & Co.	Maintains	Buy -> Buy
2025-08-08	Raymond James	Maintains	Strong Buy -> Strong Buy
2025-05-07	Guggenheim	Maintains	Buy -> Buy
2025-04-17	Wells Fargo	Initiate	Equal-Weight
2025-03-07	HC Wainwright & Co.	Reiterate	Buy -> Buy
2025-02-27	Stifel	Maintains	Buy -> Buy
2025-02-27	Goldman Sachs	Maintains	Buy -> Buy
2025-01-14	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-12-12	JMP Securities	Reiterate	Market Outperform -> Market Outperform
2024-12-04	Leerink Partners	Maintains	Outperform -> Outperform
2024-12-04	HC Wainwright & Co.	Maintains	Buy -> Buy
2024-11-08	HC Wainwright & Co.	Maintains	Buy -> Buy
2024-10-14	HC Wainwright & Co.	Reiterate	Buy -> Buy
2024-09-17	JMP Securities	Reiterate	Market Outperform -> Market Outperform
2024-09-16	Stifel	Reiterate	Buy -> Buy
2024-09-16	HC Wainwright & Co.	Maintains	Buy -> Buy
2024-09-10	Oppenheimer	Downgrade	Outperform -> Perform

Next Earnings Forecast Details

Next Earnings Details

Release Date: Apr 30, 2026
Period: Q1 / 2026
EPS Estimate: -$0.39
Revenue Estimate: 524.576K
Revenue Q2Q: -93.17%
EPS Q2Q: 15.96%
Number of Analysts: 13

Next Earnings Revisions

Revenue (1 Month)

414.29%

Revenue (3 Months)

1,957.16%

EPS (1 Month)

-0.51%

EPS (3 Months)

10.97%

Next Earnings Summary

RLAY is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.39 USD and the consensus revenue estimate is 524.58K USD.

The next earnings revenue estimate has been revised upward by 1957.16% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Revenue YoY % growth	25.546M 1,751.16%	10.007M -60.83%	15.355M 53.44%	4.103M -73.28%	17.398M 324.03%	19.979M 14.84%	89.325M 347.09%	299.51M 235.30%	591.13M 97.37%	1.017B 72.04%	873.04M -14.16%
EBITDA YoY % growth	-367.731M -24.59%	-367.004M 0.20%	-299.181M 18.48%	-292.342M 2.29%	-271.902M 6.99%	-340.848M -25.36%	-89.689M 73.69%	123.87M 238.11%	245.7M 98.35%	367.12M 49.42%	430.12M 17.16%
EBIT YoY % growth	-373M -24.63%	-372.468M 0.14%	-302.738M 18.72%	-292.25M 3.46%	-291.15M 0.38%	-280.082M 3.80%	-271.77M 2.97%	-132M 51.43%	126.94M 196.17%	446.13M 251.45%	441.58M -1.02%
Operating Margin	-1,460.11%	-3,722.07%	-1,971.59%	-7,122.84%	-1,673.47%	-1,401.88%	-304.25%	-44.07%	21.47%	43.87%	50.58%
EPS YoY % growth	-2.80 -7.69%	-2.39 14.64%	-1.62 32.22%	-1.63 -0.47%	-1.56 4.30%	-1.56 -0.02%	-0.68 56.14%	0.03 104.48%	0.98 3,116.67%	2.69 173.58%	1.96 -27.27%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26	Q1 / 27	Q2 / 27	Q3 / 27	Q4 / 27	Q1 / 28	Q2 / 28	Q3 / 28	Q4 / 28
EPS Q2Q % growth	-0.39 15.96%	-0.39 5.37%	-0.39 8.78%	-0.38 -19.10%	-0.37 4.09%	-0.37 3.64%	-0.38 2.74%	-0.32 15.69%	-0.27 28.47%	-0.31 18.14%	-0.31 19.79%	-0.19 39.68%
Revenue Q2Q % growth	524.576K -93.17%	87.424K -87.09%	72.859K	3.424M -51.09%	-100.00%	-100.00%	-100.00%	15.616M 356.07%	489.6K	489.6K	489.6K	25.99M 66.43%
EBITDA Q2Q % growth	-76.819M 8.18%	-70.774M 5.18%	-70.994M 8.32%	-64.887M -13.69%	-61.2M 20.33%	-62.22M 12.09%	-63.24M 10.92%	-47.94M 26.12%	-66.3M -8.33%	-67.32M -8.20%	-68.34M -8.06%	-44.88M 6.38%
EBIT Q2Q % growth	-68.175M 19.67%	-72.099M 6.18%	-73.733M 8.28%	-73.768M -21.67%	-61.7M 9.50%	-62.587M 13.19%	-63.485M 13.90%	-48.797M 33.85%	-66.8M -8.27%	-68.034M -8.70%	-69.289M -9.14%	-45.064M 7.65%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

1.26%

EPS Next 5 Year

15.09%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

18.51%

Revenue Next 5 Year

90.29%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

-1.56%

EBIT Next 5 Year

18.94%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

RELAY THERAPEUTICS INC / RLAY Forecast FAQ

What do analysts expect the price target to be for RELAY THERAPEUTICS INC (RLAY)?

18 analysts have analysed RLAY and the average price target is 17.43 USD. This implies a price increase of 40.02% is expected in the next year compared to the current price of 12.45.

What is the next earnings date for RLAY stock?

RELAY THERAPEUTICS INC (RLAY) will report earnings on 2026-04-30.

What are the consensus estimates for RELAY THERAPEUTICS INC (RLAY) next earnings?

The consensus EPS estimate for the next earnings of RELAY THERAPEUTICS INC (RLAY) is -0.39 USD and the consensus revenue estimate is 524.58K USD.

Can you provide the analyst count for RELAY THERAPEUTICS INC stock?

The number of analysts covering RELAY THERAPEUTICS INC (RLAY) is 18.

Analyst forecast overview

Forecast Snapshot